Hologic Inc (Hologic) develops, manufactures, and supplies medical imaging systems, diagnostic products, and surgical products. It offers products that aid the diagnosis of human diseases; breast imaging and related products and accessories; GYN surgical products, including endometrial ablation system and hysteroscopic tissue removal system; and skeletal health products such as dual-energy X-ray bone densitometry systems and mini C-arm imaging products. The company offers its solutions to surgeons, hospitals, clinical laboratories, and healthcare providers. Hologic offers its products and services through direct sales and a network of independent distributors and sales representatives. The company operates in Europe, the Americas and Asia-Pacific. Hologic is headquartered in Marlborough, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Hologic Inc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Hologic Inc Company Overview
Hologic Inc Company Snapshot
Hologic Inc Pipeline Products and Ongoing Clinical Trials Overview
Hologic Inc – Pipeline Analysis Overview
Business Description
Hologic Inc - Key Facts
Hologic Inc - Major Products and Services
Hologic Inc Pipeline Products by Development Stage
Hologic Inc Pipeline Products Overview
Access DXA
Access DXA Product Overview
CancerTARGET ID
CancerTARGET ID Product Overview
CancerTREATMENT ID
CancerTREATMENT ID Product Overview
Dia-CT/NG-050
Dia-CT/NG-050 Product Overview
Diagnostic Assay - HBV
Diagnostic Assay - HBV Product Overview
Diagnostic Assay - Women's Health
Diagnostic Assay - Women's Health Product Overview
Panther System - Chlamydia Trachomatis Assay Product Overview
Panther System - Clostridium Difficile Assay
Panther System - Clostridium Difficile Assay Product Overview
Panther System - EBV Assay
Panther System - EBV Assay Product Overview
Panther System - Gastrointestinal Infections
Panther System - Gastrointestinal Infections Product Overview
Panther System - GBS Assay
Panther System - GBS Assay Product Overview
Panther System - Monkeypox Assay
Panther System - Monkeypox Assay Product Overview
Panther System - Mycoplasma Genitalium Resistance Assay
Panther System - Mycoplasma Genitalium Resistance Assay Product Overview
Panther System - Neisseria Gonorrhoeae Assay
Panther System - Neisseria Gonorrhoeae Assay Product Overview
Panther System - SARS-CoV-2/Flu/A/B/RSV Assay
Panther System - SARS-CoV-2/Flu/A/B/RSV Assay Product Overview
Panther Trax
Panther Trax Product Overview
Quant. fFN Test
Quant. fFN Test Product Overview
Second Generation Surgical 5mm Stapler
Second Generation Surgical 5mm Stapler Product Overview
Second-Generation Prostate Cancer Assay
Second-Generation Prostate Cancer Assay Product Overview
Hologic Inc - Key Competitors
Hologic Inc - Key Employees
Hologic Inc - Key Employee Biographies
Hologic Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Recent Developments
Hologic Inc, Recent Developments
May 22, 2024: Hologic Recalls BioZorb Marker Due to Complications with Implanted Devices
May 02, 2024: Hologic Announces Financial Results for Second Quarter of Fiscal 2024
Apr 16, 2024: Hologic Receives Innovative Technology Contract From Vizient for CoolSeal Advanced Energy Portfolio and JustRight 5 mm Stapler
Mar 05, 2024: Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be over- or undertreated without Breast Cancer Index Genomic Testing
Feb 27, 2024: BioZorb Markers and Potential Risks with Use in Breast Tissue: FDA Safety Communication
Feb 14, 2024: Hologic Receives DeNovo Clearance For Genius Digital Diagnostics System
Feb 05, 2024: Hologic Receives 510(K) Clearance For Aptima Neisseria Gonorrhoeae Assay
Feb 02, 2024: FDA grants clearance for Hologic’s cervical cancer screening system
Jan 16, 2024: Cynosure Partners with LaserAway to Bring Potenza RF Microneedling, a First-of-its-Kind Technology, to Consumers Nationwide
Jan 04, 2024: Hologic to Announce Financial Results for the First Quarter of Fiscal 2024 on Thursday, February 1, 2024